Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals Wraps Up $74.8M LINCO Acquisition

NEW YORK, May 3 (GenomeWeb News) - Serologicals has completed its acquisition of LINCO, the company said today.

 

Serologicals disclosed its plan to buy it in March and said it would close last month.

 

Privately held LINCO comprises LINCO Research and LINCO Diagnostic Services. LRI sells multiplex, ELISA and RIA immunoassay products and technologies, and LDS provides bioanalytical contract services supporting research and drug development. The company is based in St. Louis.

 

As expected, Serologicals paid $64.5 million in cash for the stock of LINCO plus $10.3 million for the land and buildings the company occupies.

 

Last week, Millipore said it plans to pay $1.4 billion to acquire Serologicals.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.